Crispr Therapeutics shares owned by Nikko Asset Management Americas
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Nikko Asset Management Americas
from 13F filings
Historical chart of Nikko Asset Management Americas investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Nikko Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Nikko Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $140M | 2.2M | 64.79 |
| 2025-06-30 | $117M | 2.4M | 48.62 |
| 2025-03-31 | $86M | 2.5M | 33.99 |
| 2024-12-31 | $108M | 2.7M | 39.36 |
| 2024-09-30 | $139M | 3.0M | 46.97 |
| 2024-06-30 | $170M | 3.2M | 53.94 |
| 2024-03-31 | $223M | 3.3M | 68.13 |
| 2023-12-31 | $211M | 3.4M | 62.59 |
| 2023-09-30 | $157M | 3.5M | 45.38 |
| 2023-06-30 | $198M | 3.5M | 56.13 |
| 2023-03-31 | $179M | 4.0M | 45.00 |
| 2022-12-31 | $163M | 4.0M | 40.65 |
| 2022-09-30 | $277M | 4.3M | 65.00 |
| 2022-06-30 | $276M | 4.6M | 60.22 |
| 2022-03-31 | $291M | 4.6M | 63.00 |
| 2021-12-31 | $331M | 4.3M | 76.52 |
| 2021-09-30 | $368M | 3.3M | 112.00 |
| 2021-06-30 | $548M | 3.4M | 162.00 |
| 2021-03-31 | $446M | 3.7M | 121.85 |
| 2020-12-31 | $588M | 3.8M | 153.11 |
| 2020-09-30 | $309M | 3.7M | 83.50 |
| 2020-06-30 | $269M | 3.7M | 72.50 |
| 2020-03-31 | $160M | 3.8M | 42.41 |
| 2019-12-31 | $186M | 3.0M | 60.90 |
| 2019-09-30 | $114M | 2.8M | 40.99 |
| 2019-06-30 | $88M | 1.9M | 47.10 |
| 2019-03-31 | $16M | 441k | 35.72 |
| 2018-12-31 | $26k | 924 | 28.14 |
| 2018-09-30 | $50k | 1.1k | 44.48 |
More positions owned by Nikko Asset Management Americas
View all positions for Nikko Asset Management Americas